Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole + Capecitabine vs EC-T in Neoadjuvant ER+/HER2- Breast Cancer
NCT03507465Phase 3Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Nov 2017
- Primary completion
- Nov 2019
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole, capecitabine in breast cancer, sponsored by Guangdong Provincial People's Hospital. Status: unknown.
02
Drugs
letrozolecapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03507465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03507465.